These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8207608)

  • 1. Human papillomaviruses, p53, and cervical neoplasia.
    Lane S; Wells M
    J Pathol; 1994 Apr; 172(4):299-300. PubMed ID: 8207608
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 polymorphism and risk of cervical cancer.
    Hildesheim A; Schiffman M; Brinton LA; Fraumeni JF; Herrero R; Bratti MC; Schwartz P; Mortel R; Barnes W; Greenberg M; McGowan L; Scott DR; Martin M; Herrera JE; Carrington M
    Nature; 1998 Dec; 396(6711):531-2. PubMed ID: 9859989
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
    Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V
    Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 polymorphism and risk of cervical cancer.
    Josefsson AM; Magnusson PK; Ylitalo N; Quarforth-Tubbin P; Pontén J; Adami HO; Gyllensten UB
    Nature; 1998 Dec; 396(6711):531; author reply 532. PubMed ID: 9859988
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
    Thomas M; Pim D; Banks L
    Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P53 protein and human papillomavirus oncogenes in carcinogenesis of the uterine cervix].
    Toledo-Cuevas EM; García-Carrancá A
    Rev Invest Clin; 1996; 48(1):59-68. PubMed ID: 8815489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphology of lesions of the uterine cervix and human papillomaviruses].
    Meisels A; Morin C
    Arch Anat Cytol Pathol; 1997; 45(5):261-7. PubMed ID: 9588036
    [No Abstract]   [Full Text] [Related]  

  • 13. The natural history of cervical HPV infection: unresolved issues.
    Woodman CB; Collins SI; Young LS
    Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 functional status in HPV-positive human primary cervical carcinoma.
    Rodríguez JA; Barandika O; Innes D; Múgica van Herckenrode C
    Int J Dev Biol; 1996; Suppl 1():303S. PubMed ID: 9087808
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of p53 and HPV in cervical cancer.
    Street D; Delgado G
    Gynecol Oncol; 1995 Sep; 58(3):287-8. PubMed ID: 7672693
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomaviruses in cervical cancer: II. Application of PCR and in situ hybridization and HPV significance.
    Panotopoulou E; Troungos C; Fotiou S; Vassilandonopoulou G; Tserkezoglou A; Kittas C; Kottaridis S
    Anticancer Res; 1997; 17(1A):519-24. PubMed ID: 9066705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care].
    Sifuentes Alvarez A; Reyes Romero M
    Ginecol Obstet Mex; 2003 Jan; 71():12-5. PubMed ID: 12708345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.